David J. Mack Bio Xcel Therapeutics, Inc. (BTAI) insider trading activity

BTAI Quotes by TradingView

David J. Mack is Director of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 6,772 shares of BTAI, which is worth approximately $15,237. The most recent transaction as insider was on Feb 28, 2025, when has been sold 1,693 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.77K
75.0% 3M change
n/a 12M change
Total Value Held $15,237

DAVID J. MACK Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2025
BUY
Exercise of conversion of derivative security
-
1,693 Added 20.0%
6,772 Common Stock
Jan 31 2025
BUY
Exercise of conversion of derivative security
-
27,089 Added 25.0%
81,267 Common Stock
Dec 31 2024
BUY
Exercise of conversion of derivative security
-
27,089 Added 33.33%
54,178 Common Stock
Nov 30 2024
BUY
Exercise of conversion of derivative security
-
27,089 Added 50.0%
27,089 Common Stock
DJM

David J. Mack

Director
New Haven, CT

Track Institutional and Insider Activities on BTAI

Follow BioXcel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTAI shares.

Notify only if

Insider Trading

Get notified when an Bio Xcel Therapeutics, Inc. insider buys or sells BTAI shares.

Notify only if

News

Receive news related to BioXcel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BTAI